|
DE151036C
(enExample)
|
|
|
|
|
|
DE150423C
(enExample)
|
|
|
|
|
|
US812554A
(en)
|
1905-11-08 |
1906-02-13 |
Hoechst Ag |
Alkamin esters of para-aminobenzoic acid.
|
|
US1889645A
(en)
|
1930-12-22 |
1932-11-29 |
Winthrop Chem Co Inc |
Beta-dimethylaminoethyl ester of para-butylamino-benzoic acid
|
|
US2441498A
(en)
|
1943-07-15 |
1948-05-11 |
Astra Apotekarnes Kem Fab |
Alkyl glycinanilides
|
|
US2689248A
(en)
|
1950-06-17 |
1954-09-14 |
Sterling Drug Inc |
Tertiary-aminoalkyl 4-amino-2-alkoxybenzoates and their synth esis
|
|
US2799679A
(en)
|
1955-04-28 |
1957-07-16 |
Bofors Ab |
Process of preparing amides of heterocyclic carboxylic acids
|
|
US2883271A
(en)
|
1956-11-23 |
1959-04-21 |
Phillips Petroleum Co |
Safety system for combustion process
|
|
US2955111A
(en)
|
1957-01-28 |
1960-10-04 |
Bofors Ab |
Synthesis of n-alkyl-piperidine and n-alkyl-pyrrolidine-alpha-carboxylic acid amides
|
|
US3160662A
(en)
|
1957-06-26 |
1964-12-08 |
Astra Apotekarnes Kem Fab |
Lower alkylaminoacyl amide anesthetics
|
|
NL281394A
(enExample)
|
1961-07-25 |
|
|
|
|
DE1251764B
(de)
|
1965-08-18 |
1967-10-12 |
C H Boehnnger Sohn Ingelheim/ Rhein |
Verfahren zur Herstellung von antimikrobiell wirksamen 12 3,4-Tetra hydro 9 -ammo acridmiumverbmdungen
|
|
US3812147A
(en)
|
1970-12-22 |
1974-05-21 |
Astra Pharma Prod |
Acylxylidide local anaesthetics
|
|
US3931195A
(en)
|
1971-03-03 |
1976-01-06 |
Mead Johnson & Company |
Substituted piperidines
|
|
BE786875A
(fr)
|
1971-07-28 |
1973-01-29 |
Astra Pharma Prod |
Amide, methode pour sa preparation et ses compositions therapeutiques
|
|
US3773939A
(en)
|
1971-11-24 |
1973-11-20 |
Janssen Pharmaceutica Nv |
N-arallyl-n'-aralkyl piperazine pharmaceutical compositions
|
|
US4069309A
(en)
|
1972-09-19 |
1978-01-17 |
Avon Products, Inc. |
Cationic skin substantive sunscreen composition and method
|
|
US3900481A
(en)
|
1974-04-01 |
1975-08-19 |
Riker Laboratories Inc |
Derivatives of pyrrolidine and piperidine
|
|
CS195321B2
(en)
|
1975-12-23 |
1980-01-31 |
Ciba Geigy Ag |
Plant growth suppressing agents
|
|
US4070347A
(en)
|
1976-08-16 |
1978-01-24 |
Alza Corporation |
Poly(orthoester) co- and homopolymers and poly(orthocarbonate) co- and homopolymers having carbonyloxy functionality
|
|
DE2915250A1
(de)
|
1979-04-14 |
1980-10-30 |
Basf Ag |
Salze von alpha -aminoacetaniliden
|
|
US4293539A
(en)
|
1979-09-12 |
1981-10-06 |
Eli Lilly And Company |
Controlled release formulations and method of treatment
|
|
US4877805A
(en)
|
1985-07-26 |
1989-10-31 |
Kligman Albert M |
Methods for treatment of sundamaged human skin with retinoids
|
|
US4757128A
(en)
|
1986-08-01 |
1988-07-12 |
Massachusetts Institute Of Technology |
High molecular weight polyanhydride and preparation thereof
|
|
US5169637A
(en)
|
1983-03-24 |
1992-12-08 |
The Liposome Company, Inc. |
Stable plurilamellar vesicles
|
|
AU560367B2
(en)
|
1983-08-01 |
1987-04-02 |
Astra Lakemedel Aktiebolag |
L-n-n-propylpipecolic acid-2,6-xylidide and method for preparing the same
|
|
CA1237671A
(en)
|
1983-08-01 |
1988-06-07 |
Michael W. Fountain |
Enhancement of pharmaceutical activity
|
|
US5409704A
(en)
|
1985-06-26 |
1995-04-25 |
The Liposome Company, Inc. |
Liposomes comprising aminoglycoside phosphates and methods of production and use
|
|
US4975282A
(en)
|
1985-06-26 |
1990-12-04 |
The Liposome Company, Inc. |
Multilamellar liposomes having improved trapping efficiencies
|
|
US5023087A
(en)
|
1986-02-10 |
1991-06-11 |
Liposome Technology, Inc. |
Efficient method for preparation of prolonged release liposome-based drug delivery system
|
|
IE60901B1
(en)
|
1986-08-21 |
1994-08-24 |
Vestar Inc |
Improved treatment of systemic fungal infections with phospholipid particles encapsulating polyene antifungal antibiotics
|
|
US5049388A
(en)
|
1986-11-06 |
1991-09-17 |
Research Development Foundation |
Small particle aerosol liposome and liposome-drug combinations for medical use
|
|
CA1319144C
(en)
|
1986-11-14 |
1993-06-15 |
Quirico Branca |
Tetrahydronaphthalene derivatives
|
|
US5032582A
(en)
|
1987-02-27 |
1991-07-16 |
Liposome Technology, Inc. |
Method for treating fungal infections with amphotericin B/cholesterol sulfate composition
|
|
US4994213A
(en)
|
1988-05-17 |
1991-02-19 |
Liposome Technology, Inc. |
Method of preparing lipid structures
|
|
US5082866A
(en)
|
1988-06-01 |
1992-01-21 |
Odontex, Inc. |
Biodegradable absorption enhancers
|
|
US4980378A
(en)
|
1988-06-01 |
1990-12-25 |
Odontex, Inc. |
Biodegradable absorption enhancers
|
|
US5194581A
(en)
|
1989-03-09 |
1993-03-16 |
Leong Kam W |
Biodegradable poly(phosphoesters)
|
|
US5194266A
(en)
|
1989-08-08 |
1993-03-16 |
Liposome Technology, Inc. |
Amphotericin B/cholesterol sulfate composition and method
|
|
US5356633A
(en)
|
1989-10-20 |
1994-10-18 |
Liposome Technology, Inc. |
Method of treatment of inflamed tissues
|
|
DE69211691T2
(de)
|
1991-04-19 |
1997-01-16 |
Nexstar Pharmaceuticals Inc., Boulder, Col. |
Pharmazeutische formulierung und pharmazeutisches verfahren
|
|
US5176907A
(en)
|
1991-08-13 |
1993-01-05 |
The Johns Hopkins University School Of Medicine |
Biocompatible and biodegradable poly (phosphoester-urethanes)
|
|
GR1002207B
(en)
|
1992-08-06 |
1996-03-27 |
Johnson & Johnson Consumer |
Skin care compositions containing imidazoles.
|
|
US5552155A
(en)
|
1992-12-04 |
1996-09-03 |
The Liposome Company, Inc. |
Fusogenic lipsomes and methods for making and using same
|
|
US5480971A
(en)
*
|
1993-06-17 |
1996-01-02 |
Houghten Pharmaceuticals, Inc. |
Peralkylated oligopeptide mixtures
|
|
US6051576A
(en)
|
1994-01-28 |
2000-04-18 |
University Of Kentucky Research Foundation |
Means to achieve sustained release of synergistic drugs by conjugation
|
|
US5591317A
(en)
|
1994-02-16 |
1997-01-07 |
Pitts, Jr.; M. Michael |
Electrostatic device for water treatment
|
|
US5716622A
(en)
|
1995-01-06 |
1998-02-10 |
The Rockefeller University |
Functionally active regions of signal transducer and activators of transcription
|
|
US5783683A
(en)
|
1995-01-10 |
1998-07-21 |
Genta Inc. |
Antisense oligonucleotides which reduce expression of the FGFRI gene
|
|
AU5938996A
(en)
|
1995-06-07 |
1996-12-30 |
Nexstar Pharmaceuticals, Inc. |
Method for encapsulating pharmaceutical materials
|
|
US5747470A
(en)
|
1995-06-07 |
1998-05-05 |
Gen-Probe Incorporated |
Method for inhibiting cellular proliferation using antisense oligonucleotides to gp130 mRNA
|
|
US6413961B1
(en)
|
1995-12-12 |
2002-07-02 |
Omeros Medical Systems, Inc. |
Irrigation solution and method for inhibition of pain and inflammation
|
|
SE508357C2
(sv)
|
1996-01-02 |
1998-09-28 |
Kay Laserow |
Mätinstrument för mätning av smärta jämte ett förfarande för att med ett mätinstrument mäta smärta
|
|
WO1998024428A1
(en)
|
1996-12-02 |
1998-06-11 |
Brigham & Women's Hospital, Inc. |
Long-acting local anesthetics
|
|
SE9604751D0
(sv)
|
1996-12-20 |
1996-12-20 |
Astra Ab |
New therapy
|
|
US5837713A
(en)
*
|
1997-02-26 |
1998-11-17 |
Mayo Foundation For Medical Education And Research |
Treatment of eosinophil-associated pathologies by administration of topical anesthetics and glucocorticoids
|
|
EP0991699B1
(en)
|
1997-06-18 |
2002-04-24 |
Guilford Pharmaceuticals Inc. |
Two-stage solution polymerization of high molecular weight poly(phosphoesters)
|
|
US6028163A
(en)
|
1997-06-27 |
2000-02-22 |
Guilford Pharmaceuticals Inc. |
Solution polymerization of high molecular weight poly(phosphoesters) in toluene
|
|
EP0997147B1
(en)
|
1997-07-08 |
2006-03-15 |
Ono Pharmaceutical Co., Ltd. |
Amino acid derivatives
|
|
TW536401B
(en)
|
1997-09-03 |
2003-06-11 |
Cardiome Pharma Corp |
A pharmaceutical composition of N,N-bis(phenylcarbamoylmethyl)dimethylammomum chloride and derivatives for the treatment of pain
|
|
US6623040B1
(en)
|
1997-09-03 |
2003-09-23 |
Recot, Inc. |
Method for determining forced choice consumer preferences by hedonic testing
|
|
US6083996A
(en)
|
1997-11-05 |
2000-07-04 |
Nexmed Holdings, Inc. |
Topical compositions for NSAI drug delivery
|
|
KR20010072593A
(ko)
|
1998-06-09 |
2001-07-31 |
추후보정 |
기침 치료용 조성물 및 기침 치료방법
|
|
US6153212A
(en)
|
1998-10-02 |
2000-11-28 |
Guilford Pharmaceuticals Inc. |
Biodegradable terephthalate polyester-poly (phosphonate) compositions, articles, and methods of using the same
|
|
US6103255A
(en)
|
1999-04-16 |
2000-08-15 |
Rutgers, The State University |
Porous polymer scaffolds for tissue engineering
|
|
US6118020A
(en)
|
1999-05-19 |
2000-09-12 |
Nexmed Holdings, Inc. |
Crystalline salts of dodecyl 2-(N,N-dimethylamino)-propionate
|
|
WO2001025234A1
(en)
*
|
1999-10-01 |
2001-04-12 |
Advanced Medicine, Inc. |
Quinazolinones and analogues and their use as local anesthetics
|
|
AU2334501A
(en)
*
|
1999-12-15 |
2001-06-25 |
Ucb Farchim Sa |
Cyclic quaternary ammonium compounds
|
|
WO2001044218A1
(en)
|
1999-12-15 |
2001-06-21 |
Ucb Farchim S.A. |
Quaternary salts of n-substituted cyclic or acyclic amines as pharmaceuticals
|
|
WO2001045678A2
(de)
|
1999-12-21 |
2001-06-28 |
Id Pharma Gmbh |
Arzneimittel, verfahren zu dessen herstellung und dessen verwendung
|
|
WO2001083828A1
(en)
|
2000-05-04 |
2001-11-08 |
Dzgenes, Llc |
TGFβ-RII PROMOTER POLYMORPHISMS
|
|
WO2002000218A2
(en)
*
|
2000-06-23 |
2002-01-03 |
Mayo Foundation For Medical Education And Research |
Methods of treating neutrophil-related diseases with topical anesthetics
|
|
DE10039449A1
(de)
|
2000-08-11 |
2003-07-24 |
Id Pharma Gmbh I Ins |
Verwendung einer lokalanästhetikumhaltigen Zusammensetzung zur Behandlung von Hyperalgesien
|
|
US6766319B1
(en)
|
2000-10-31 |
2004-07-20 |
Robert J. Might |
Method and apparatus for gathering and evaluating information
|
|
US6884782B2
(en)
|
2000-11-08 |
2005-04-26 |
Amgen Inc. |
STAT modulators
|
|
US20030152637A1
(en)
|
2001-01-25 |
2003-08-14 |
Mark Chasin |
Local anesthetic, and method of use
|
|
US20040146590A1
(en)
|
2001-03-22 |
2004-07-29 |
Iadarola Michael J |
Molecular neurochirurgie for pain control administering locally capsaicin or resinferatoxin
|
|
US20030027833A1
(en)
|
2001-05-07 |
2003-02-06 |
Cleary Gary W. |
Compositions and delivery systems for administration of a local anesthetic agent
|
|
EP1399440B1
(en)
|
2001-06-15 |
2009-06-03 |
Vertex Pharmaceuticals Incorporated |
5-(2-aminopyrimidin-4-yl)benzisoxazoles as protein kinase inhibitors
|
|
ITMI20012025A1
(it)
|
2001-09-28 |
2003-03-28 |
Dompe Spa |
Sali di ammonio quaternari di omega-amminoalchilammidi di acidi r 2-aril-propionici e composizioni farmaceutiche che li contengono
|
|
AU2003254426A1
(en)
|
2002-08-02 |
2004-02-23 |
Universite Libre De Bruxelles |
Apolipoprotein l-i for the treatment or diagnosis of prypanosomaldiseases
|
|
EA012599B1
(ru)
|
2003-04-10 |
2009-10-30 |
Ньюроджескс, Инк. |
Способы и композиции для введения агонистов trpv1
|
|
US20040220187A1
(en)
*
|
2003-04-22 |
2004-11-04 |
Pharmacia Corporation |
Compositions of a cyclooxygenase-2 selective inhibitor and a sodium ion channel blocker for the treatment of pain, inflammation or inflammation mediated disorders
|
|
WO2004093813A2
(en)
|
2003-04-22 |
2004-11-04 |
Pharmacia Corporation |
Compositions of a cyclooxygenase-2 selective inhibitor and a calcium modulating agent for the treatment of pain, inflammation or inflammation mediated disorders
|
|
ES2223277B1
(es)
|
2003-06-19 |
2006-03-01 |
Fernando Bouffard Fita |
Composicion anestesica para administracion topica.
|
|
US8361467B2
(en)
|
2003-07-30 |
2013-01-29 |
Depuy Spine, Inc. |
Trans-capsular administration of high specificity cytokine inhibitors into orthopedic joints
|
|
NO20034069L
(no)
|
2003-09-12 |
2005-03-14 |
Aximed As |
Fremstilling og bruk av capsaicinderivater
|
|
US20070149469A1
(en)
|
2003-10-02 |
2007-06-28 |
Christian Korherr |
Medical use of tbk-1 or of inhibitors thereof
|
|
US20050142596A1
(en)
|
2003-11-14 |
2005-06-30 |
Krolewski Andrzej S. |
Methods of diagnosing renal and cardiovascular disease
|
|
PT1701941E
(pt)
|
2003-12-11 |
2012-08-03 |
Univ Texas |
Compostos para o tratamento de doenças proliferativas celulares
|
|
US20070196866A1
(en)
|
2004-03-13 |
2007-08-23 |
Irm Llc |
Modulators of ion channel trpa1
|
|
US7161034B2
(en)
|
2004-04-20 |
2007-01-09 |
Dade Behring Inc. |
Lidocaine analogs and methods of making and using same
|
|
WO2005105814A1
(en)
|
2004-04-28 |
2005-11-10 |
Incyte Corporation |
Tetracyclic inhibitors of janus kinases
|
|
ES2542847T3
(es)
|
2004-06-02 |
2015-08-12 |
Neurogesx Inc. |
Formulaciones que comprenden capsaicina, un anestésico local y/o un agente antipruriginoso para el tratamiento del dolor
|
|
ES2651021T3
(es)
|
2004-07-24 |
2018-01-23 |
Laboratorios Del Dr. Esteve, S.A. |
Uso de compuestos activos sobre el receptor sigma para el tratamiento de alodinia mecánica
|
|
ITMI20041566A1
(it)
|
2004-07-30 |
2004-10-30 |
Indena Spa |
"trpv1 agonisti, formulazioni che li contengono e loro usi"
|
|
WO2006036180A1
(en)
*
|
2004-09-20 |
2006-04-06 |
Corus Pharma, Inc. |
Targeted delivery of lidocaine and other local anesthetics and a method for treatment of cough and tussive attacks
|
|
US7947682B2
(en)
|
2004-12-29 |
2011-05-24 |
University Of Southern California |
Substituted N′-pyrrolo[1,2-a]quinoxalin-4-yl-hydrazides as anti-cancer agents
|
|
US20060134008A1
(en)
|
2004-12-16 |
2006-06-22 |
Daniel Deaver |
Compositions and methods for pulmonary conditions
|
|
AR054416A1
(es)
|
2004-12-22 |
2007-06-27 |
Incyte Corp |
Pirrolo [2,3-b]piridin-4-il-aminas y pirrolo [2,3-b]pirimidin-4-il-aminas como inhibidores de las quinasas janus. composiciones farmaceuticas.
|
|
US20070149506A1
(en)
|
2005-09-22 |
2007-06-28 |
Arvanitis Argyrios G |
Azepine inhibitors of Janus kinases
|
|
ES2542989T3
(es)
|
2005-10-12 |
2015-08-13 |
Idera Pharmaceuticals, Inc. |
Compuestos oligonucleótidos inmuno reguladores (IRO) para modular la respuesta inmune basada en receptor semejante a Toll
|
|
KR101391900B1
(ko)
|
2005-12-13 |
2014-05-02 |
인사이트 코포레이션 |
야누스 키나아제 억제제로서의 헤테로아릴 치환된 피롤로［2,3-ｂ］피리딘 및 피롤로［2,3-ｂ］피리미딘
|
|
AU2006329202A1
(en)
|
2005-12-21 |
2007-06-28 |
Painceptor Pharma Corporation |
Compositions and methods for modulating gated ion channels
|
|
GB0526244D0
(en)
*
|
2005-12-22 |
2006-02-01 |
Novartis Ag |
Organic compounds
|
|
EP1867338A1
(en)
|
2006-05-30 |
2007-12-19 |
Université Libre De Bruxelles |
Pharmaceutical composition comprising apolipoproteins for the treatment of human diseases
|
|
JP2010510227A
(ja)
*
|
2006-11-20 |
2010-04-02 |
プレジデント アンド フェロウズ オブ ハーバード カレッジ |
痛みおよび痒みの治療方法、組成物およびキット
|
|
EP2121692B1
(en)
|
2006-12-22 |
2013-04-10 |
Incyte Corporation |
Substituted heterocycles as janus kinase inhibitors
|
|
WO2009026107A1
(en)
|
2007-08-17 |
2009-02-26 |
Portola Pharmaceuticals, Inc. |
Protein kinase inhibitors
|
|
CN101156851A
(zh)
*
|
2007-09-27 |
2008-04-09 |
刘全胜 |
盐酸尼卡地平分散片及其制备方法
|
|
CA2717042A1
(en)
|
2008-03-11 |
2009-09-17 |
The General Hospital Corporation |
Methods, compositions, and kits for treating pain and pruritis
|
|
US8138339B2
(en)
|
2008-04-16 |
2012-03-20 |
Portola Pharmaceuticals, Inc. |
Inhibitors of protein kinases
|
|
US8258144B2
(en)
|
2008-04-22 |
2012-09-04 |
Portola Pharmaceuticals, Inc. |
Inhibitors of protein kinases
|
|
NZ590372A
(en)
|
2008-07-08 |
2012-09-28 |
Univ Texas |
Novel inhibitors of proliferation and activation of signal transducer and activator of transcription (stats)
|
|
DE102008037682A1
(de)
*
|
2008-08-14 |
2010-04-08 |
Strackharn, Klaus, Dr.med. |
Verwendung äquipotenter Dosierungen von Lokalanästetika oder Derivaten davon zur Therapie chronischer Schmerzen
|
|
CN101347427A
(zh)
*
|
2008-09-22 |
2009-01-21 |
北京理工大学 |
一种沙坦化合物或其可药用盐和钙通道阻断剂或可药用盐的复方
|
|
CL2009001884A1
(es)
|
2008-10-02 |
2010-05-14 |
Incyte Holdings Corp |
Uso de 3-ciclopentil-3-[4-(7h-pirrolo[2,3-d]pirimidin-4-il)-1h-pirazol-1-il)propanonitrilo, inhibidor de janus quinasa, y uso de una composición que lo comprende para el tratamiento del ojo seco.
|
|
KR20110071108A
(ko)
|
2008-10-06 |
2011-06-28 |
이데라 파마슈티칼즈, 인코포레이티드 |
고콜레스테롤혈증 및 고지혈증 및 이에 관련된 질병의 예방 및 치료에서 톨-유사 수용체의 저해제의 용도
|
|
WO2010111471A2
(en)
|
2009-03-27 |
2010-09-30 |
Merck Sharp & Dohme Corp. |
RNA INTERFERENCE MEDIATED INHIBITION OF SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 1 (STAT1) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
|
|
JP6205133B2
(ja)
|
2009-07-10 |
2017-09-27 |
プレジデント アンド フェローズ オブ ハーバード カレッジ |
抗炎症剤としての恒久的に荷電したナトリウムおよびカルシウムチャンネルブロッカー
|
|
US9023355B2
(en)
|
2010-04-13 |
2015-05-05 |
Beth Israel Deaconess Medical Center, Inc. |
Compositions and methods for treating renal disease
|
|
US9828637B2
(en)
|
2010-04-18 |
2017-11-28 |
Wake Forest University Health Sciences |
Methods of predicting predisposition to or risk of kidney disease
|
|
WO2012030912A1
(en)
|
2010-09-01 |
2012-03-08 |
Ambit Biosciences Corporation |
7-cyclylquinazoline derivatives and methods of use thereof
|
|
US8822537B2
(en)
|
2012-09-27 |
2014-09-02 |
Achelios Therapeutics, Inc. |
Topical ketoprofen composition
|
|
RU2018107695A
(ru)
|
2015-08-03 |
2019-09-05 |
Президент Энд Феллоуз Оф Гарвард Колледж |
Заряженные блокаторы ионных каналов и способы их применения
|